ING GROEP NV - ACELRX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ING GROEP NV ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$58,000
-31.0%
25,000
-35.9%
0.00%
-50.0%
Q2 2017$84,000
-31.7%
39,0000.0%0.00%0.0%
Q1 2017$123,000
+251.4%
39,000
+200.0%
0.00%
+100.0%
Q4 2016$35,00013,0000.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 3,731,342$8,022,0000.40%
WealthTrust Axiom LLC 210,000$451,0000.17%
Palo Alto Investors LP 1,032,715$2,220,0000.10%
ELEMENT CAPITAL MANAGEMENT LLC 144,536$311,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 49,761$107,0000.06%
Joel Isaacson & Co., LLC 70,660$152,0000.03%
LMR Partners LLP 148,309$319,0000.02%
LINCOLN CAPITAL CORP 10,000$22,0000.02%
Malaga Cove Capital, LLC 13,150$28,0000.02%
Cornerstone Capital, Inc. 30,000$65,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders